The latest lymphoma news
Results from the phase III frontMIND trial show that adding tafasitamab and lenalidomide to R-CHOP…
On March 20, 2026, the Food and Drug Administration approved nivolumab with doxorubicin, vinblastine, and…
Eye experts at Flinders University have released new global findings that reveal how a rare…
Unlike some other forms of lymphoma, advanced-stage follicular lymphoma is considered incurable. But a new…
On February 19, 2026, the Food and Drug Administration approved acalabrutinib tablets and capsules in…
Immune cells called B cells make antibodies that fight off invading bacteria, viruses, and other…
Burkitt’s lymphoma is a rare and aggressive blood cancer characterised by a translocation of the…
On December 4, 2025, the Food and Drug Administration approved lisocabtagene maraleucel for adults with relapsed…
Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive…
On November 18, 2025, the Food and Drug Administration approved epcoritamab-bysp with lenalidomide and rituximab for…